Skip to main content
. 2018 Feb 7;15(4):5185–5192. doi: 10.3892/ol.2018.7992

Figure 3.

Figure 3.

Kaplan-Meier curves representing OS in GAC patients with RAB1A and HER-2. (A) Kaplan-Meier curves representing OS in GAC patients according to RAB1A expression; the OS duration was shorter in patients with high RAB1A levels than in patients with low RAB1A levels (P<0.001). (B) Kaplan-Meier curves representing OS in GAC patients according to the HER-2 amplification status; the OS duration was not significantly different between the HER-2-positive and HER-2-negative groups (P=0.069). (C) Kaplan-Meier survival curves based on HER-2 amplification and RAB1A expression level. Patients with positive HER-2 amplification and RAB1A expression had a significantly poorer survival than did patients without (P=0.001). OS, overall survival; CAG, gastric adenocarcinoma; HER-2, human epidermal growth factor receptor 2.